Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P274: Factors driving treatment escalation in Crohn’s disease in the CALM trialECCO '18 Vienna
Year: 2018
Authors:

W. Reinisch1*, R. Panaccione2, P. Bossuyt3, F. Baert4, A. Armuzzi5, X. Hebuterne6,7, S. Danese8, W.J. Sandborn9, S. Schreiber10, G. D'Haens11, S. Berg12, Q. Zhou13, J. Petersson13, E. Neimark13, A.M. Robinson13, J.-F. Colombel14

1Medical University of Vienna, Vienna, Austria, 2University of Calgary, Calgary, Canada, 3Imelda General Hospital, Bonheiden, Belgium, 4AZ Delta Roeselare-Menen, Menen, Belgium, 5Presidio Columbus, Fondazione Policlinico Gemelli Università Cattolica, Rome, Italy, 6Service de Gastroentérologie et Nutrition Clinique, Nice, France, 7Université de Nice-Sophia-Antipolis, Nice, France, 8Istituto Clinico Humanitas, Milan, Italy, 9University of California San Diego, La Jolla, USA, 10University Hospital Schleswig-Holstein, Kiel, Germany, 11Academic Medical Center, Amsterdam, The Netherlands, 12AbbVie AB, Solna, Sweden, 13AbbVie Inc., North Chicago, USA, 14Icahn School of Medicine at Mount Sinai, New York, USA

P275: Clinical characteristics, associated malignancies and management of primary sclerosing colangitis in inflammatory bowel disease patients: A Spanish nationwide study based on the ENEIDA registryECCO '18 Vienna
Year: 2018
Authors:

I. Guerra1*, L. Bujanda2,3, J. Castro4, O. Merino5, J. Tosca6, B. Camps7, A. Gutiérrez8, J. Gordillo9, L. de Castro10, M. Iborra3,11, A.Y. Carbajo12, C. Taxonera13, I. Rodriguez - Lago14, F. Mesonero15, R. de Francisco16, G.J. Gómez-Gómez17, M. Chaparro3,18, C.A. Tardillo19, M. Rivero20, A. Algaba1, E. Martín-Arranz21, F. Cañete3,22, R. Vicente23, B. Sicilia24, B. Antolín25, V. Prieto26, L. Márquez27, J.M. Benítez28, P. Camo29, M. Piqueras30, C.J. Gargallo31, E. Hinojosa32, J.M. Huguet33, J.L. Pérez Calle34, M. Van Domselaar35, C. Rodriguez36, X. Calvet3,37, M.C. Muñoz38, M.F. García-Sepulcre39, F. Bermejo1, J.M. Bañales40, J.P. Gisbert3,18

1Hospital Universitario de Fuenlabrada, Department of Gastroenterology, Fuenlabrada, Spain, 2Hospital Donostia/Instituto Biodonostia, Universidad del País Vasco UPV/EHU, Department of Gatroenterology, Donostia-San Sebastian, Spain, 3Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain, Spain, 4Hospital Clinic de Barcelona, Department of Gastroenterology, Barcelona, Spain, 5Hospital Universitario de Cruces, Department of Gastroenterology, Baracaldo, Vizcaya, Spain, 6Hospital Universitario Clínico de Valencia, Department of Medicine, University of Valencia, Valencia, Spain, 7Hospital Universitari de Bellvitge-IDIBELL, Department of Gastroenterology, Barcelona, Spain, 8Hospital General Universitario de Alicante, Department of Gastroenterology, Alicante, Spain, 9Hospital de la Santa Creu i Sant Pau, Department of Gastroenterology, Barcelona, Spain, 10Complexo Hospitalario Universitario de Vigo, Instituto de Investigación Biomédica. Estructura Organizativa de Xestión Integrada de Vigo, Department of Gastroenterology, Vigo, Spain, 11Hospital Universitari i Politecnic La Fe, Department of Gastroenterology, Valencia, Spain, 12Hospital Universitario Rio Hortega, Department of Gastroenterology, Valladolid, Spain, 13Hospital Clínico San Carlos and Instituto de Investigación del Hospital Clínico San Carlos (IdISSC), Department of Gastroenterology, Madrid, Spain, 14Hospital de Galdakao, Department of Gastroenterology, Galdakao, Vizcaya, Spain, 15Hospital Universitario Ramón y Cajal, Department of Gastroenterology, Madrid, Spain, 16Hospital Universitario Central De Asturias, Department of Gastroenterology, Oviedo, Spain, 17Hospital 12 de Octubre, Department of Gastroenterology, Madrid, Spain, 18Hospital Universitario de La Princesa, Gastroenterology Unit, IIS-IP, Madrid, Spain, 19Hospital Universitario Nuestra Señora Candelaria, Department of Gastroenterology, Santa Cruz De Tenerife, Spain, 20Hospital Universitario Marques de Valdecilla, Department of Gastroenterology, Unit EII, Santander, Spain, 21Hospital Universitario La Paz, Department of Gastroenterology, Madrid, Spain, 22Hospital Universitari Germans Trias I Pujol, Department of Gastroenterology, Badalona, Spain, 23Hospital Universitario Miguel Servet, Department of Gastroenterology, Zaragoza, Spain, 24Hospital Universitario de Burgos, Department of Gastroenterology, Burgos, Spain, 25Hospital Clínico Universitario de Valladolid, Department of Gastroenterology, Valladolid, Spain, 26Hospital Universitario de Salamanca, Department of Gastroenterology, Salamanca, Spain, 27Parc de Salut Mar, Department of Gastroenterology, Barcelona, Spain, 28Hospital Universitario Reina Sofia, Department of Gastroenterology, Córdoba, Spain, 29Hospital General San Jorge, Department of Hepatology and Gastroenterology, Huesca, Spain, 30Consorci Sanitari Terrassa, Terrassa, Spain, 31Hospital Clínico Universitario "Lozano Blesa" and Aragón Health Research Institute (IIS Aragón), Department of Gastroenterology, Zaragoza, Spain, 32Hospital de Manises, Department of Gastroenterology, Valencia, Spain, 33Hospital General Universitario de Valencia, Department of Gastroenterology, Valencia, Spain, 34Hospital Universitario Fundación Alcorcón, Department of Gastroenterology, Madrid, Spain, 35Hospital Universitario de Torrejón, Department of Gastroenterology, Torrejón De Ardoz, Spain, 36Complejo hospitalario de Navarra, Department of Gastroenterology and Hepatology, Pamplona, Spain, 37Corporació Sanitària Universitària Parc Taulí, Universitat Autònoma de Barcelona, Sabadell, Spain, 38Hospital Universitario de Basurto, Department of Gastroenterology, Bilbao, Spain, 39Hospital de Elche, Department of Gastroenterology, Alicante, Spain, 40Head, Liver Diseases Group Biodonostia Research Institute-Donostia University Hospital- Assistant Professor of Medicine/Sciences University of Navarra, USA., Donostia, Spain

P276: Risk matrix model for prediction of one-year surgery in Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

N. Imperatore*, A. Rispo, A. Testa, L. Bucci, G. Luglio, G.D. De Palma, M. Rea, O.M. Nardone, N. Caporaso, F. Castiglione

School of Medicine Federico II of Naples, Department of Clinical Medicine and Surgery, Naples, Italy

P277: A new pan enteric capsule for suspected or established IBD: A feasibility study assessing the system functionality to visualise and assess the small and large bowelsECCO '18 Vienna
Year: 2018
Authors:

R. Eliakim1*, C. Spada2, I. Fernandez-Urien Sainz3, H. Yanai4, A. Lahat1, Y. Ron4, S. Pecere2, G. Costamagna2, A. Schwartz5, I. Eyal6, A. Lapidus6, S. Adler5

1Sheba Medical Center, Institute of Gastroenterology, Ramat Gan, Israel, 2Policlinico Universitario “A Gemelli”, UO di Endoscopia Digestiva Chirurgica, Rome, Italy, 3Complejo Hospitalario de Navarra, Servicio de Digestivo, Pamplona, Spain, 4Sourasky Medical Center, Gastroenterology, Tel-Aviv, Israel, 5Shaare Tzedek Medical Center, Gastroenterology, Jerusalem, Israel, 6Medtronic Inc., Yoqneam, Israel

P278: Risk factors analysis for progression of low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis according to the SCENIC terminologyECCO '18 Vienna
Year: 2018
Authors:

N. Hida1*, K. Watanabe2, T. Miyazaki1, Y. Yokoyama1, T. Takagawa2, K. Kamikozuru1, M. Kawai1, Y. Kita1, T. Sato1, S. Nakamura1

1Hyogo College of Medicine, Department of Inflammatory Bowel Disease, Nishinomiya, Hyogo, Japan, 2Hyogo College of Medicine, Department of Intestinal Inflammation Research, Nishinomiya, Hyogo, Japan

P279: Vedolizumab is safe for use in pregnant patients with IBD; report of our preliminary dataECCO '18 Vienna
Year: 2018
Authors:

A. Bar-Gil Shitrit1*, B. Koslowsky2, Y. Milgrom2, A. Lahat3, E. Goldin2, S. Granovsky- Grisaru4

1Shaare Zedek Medical Center, Digestive Diseases Institute, Jerusalem, Israel, 2Shaare Zedek Medical Center, Digestive diseases institute, Jerusalem, Israel, 3Sheba Medical Center, Gastroenterology, Ramat Gan, Israel, 4Shaare Zedek Medical Center, Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Jerusalem, Israel

P280: Reducing the overprescribing of oral corticosteroids in IBD using a steroid assessment toolECCO '18 Vienna
Year: 2018
Authors:

G. Scott1*, N. Roads1, W. Lewis2

1East Kent Hospitals University NHS Foundation Trust, Gastroenterology, Canterbury, UK, 2Medway Maritime Hospital, Gastroenterology, Gillingham, UK

P281: Combined clinical and biological response (concomitant CRP and faecal calprotectin reductions) in induction and maintenance from the phase 3 ustekinumab Crohn’s disease studiesECCO '18 Vienna
Year: 2018
Authors:

J.-F. Colombel1*, C. Gasink2, A. Oortwijn3, R. van Kruchten3, S. Sloan2, V. Laliman4, P. Rutgeerts5, S. Ghosh6, W. Sandborn7, B. Feagan8, B. Sands1

1Icahn School of Medicine at Mount Sinai, New York, USA, 2Janssen Scientific Affairs, LLC., Horsham, USA, 3Janssen Biologics B.V, Leiden, The Netherlands, 4Amaris International Consultancy, Toronto, Canada, 5University Hospital, Gasthuisberg, Leuven, Belgium, 6University of Birmingham, Birmingham, UK, 7University of California San Diego, La Jolla, USA, 8University of Western Ontario, Robarts Research Institute, London, Canada

P282: Despite surveillance and increased use of biologics and immunosuppressives colorectal cancer detection in IBD patients remains unchanged over the past ten yearsECCO '18 Vienna
Year: 2018
Authors:

U.N. Shivaji1*, S.C.L. Smith1,2, R. Hejmadi3, T. Iqbal1, N. Bhala1, R. Cooney1, S. Ghosh1,2, M. Iacucci1,2

1University Hospital Birmingham, Department of Gastroenterology, Birmingham, UK, 2Institute of Translational Medicine, Birmingham, UK, 3University Hospital Birmingham, Histopathology, Birmingham, UK

P283: Predicting outcomes in paediatric Crohn’s disease: A systematic reviewECCO '18 Vienna
Year: 2018
Authors:

A. Ricciuto1*, M. Aardoom2, E. Orlanski-Meyer3, N. Carman4, D. Turner3, L. de Ridder2, A. Griffiths1

1Hospital for Sick Children, University of Toronto, Toronto, Canada, 2Erasmus Medical Center Children's Hospital, Department of Paediatric Gastroenterology, Rotterdam, The Netherlands, 3The Juliet Keidan Institute of Pediatric Gastroenterology and Nutrition, Shaare Zedek Medical Center, Jerusalem, Israel, 4Children's Hospital of Eastern Ontario, Department of Gastroenterology, Hepatology and Nutrition, Ottawa, Canada

P284: Risk of colorectal neoplasia, colectomy and responsiveness to biologic therapy in patients with inflammatory bowel disease and concomitant primary sclerosing cholangitis: A systematic reviewECCO '18 Vienna
Year: 2018
Authors:

K. Wu, A. Thompson, N. Sheng Ding*

St Vincent's Hospital Melbourne, Gastroenterology, Fitzroy, Australia

P285: Crohn’s disease overall severity is predictive of disabling disease: Disease severity index evaluationECCO '18 Vienna
Year: 2018
Authors:

J. Pereira Rodrigues*, M. Sousa, J.C. Silva, T. Freitas, A.P. Silva, A. Rodrigues, J. Carvalho

Centro Hospitalar Vila Nova de Gaia/Espinho, Gastroenterology, Vila Nova de Gaia, Portugal

P286: Differentiation of Crohn’s disease and ulcerative colitis in comparison with healthy controls using intestinal wall thickness of the colon: A diagnostic accuracy study of endoscopic ultrasonographyECCO '18 Vienna
Year: 2018
Authors:

N. Roushan1, A. Niksirat2*, N. Ebrahimi Daryani3, Z. Azizi4, H. Pournaghshband4

1Tehran University of medical Sciences, Tehran, Iran, Islamic Republic of, 2Tehran university of medical sciences, Internal medicine, Tehran, Iran, Islamic Republic of, 3Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of, 4Iran university of medical sciences, Tehran, Iran, Islamic Republic of

P287: Clinical course of Crohn’s disease followed up in a period of six years in one reference centreECCO '18 Vienna
Year: 2018
Authors:

A. Georgieva*, A. Atanassova, I. Kotzev

Medical University Varna, Clinic of Hepatogastroenterology, St. Marina University Hospital, Varna, Bulgaria

P288: Pregnancy and delivery outcomes in patients with ulcerative colitisECCO '18 Vienna
Year: 2018
Authors:

S. Kashiwagi*, K. Uchiyama, Y. Toyokawa, O. Handa, H. Yasuda, J. Sakagami, H. Konishi, T. Takagi, Y. Naito, Y. Itoh

Kyoto Prefectural University of Medicine, Department of Gastroenterology and Hepatology, Kyoto-shi, Japan

P289: Transcutaneous nonlinearity strain ultrasound differentiates early vs. advanced fibrotic intestine in vivo in the TNBS rat model and is feasible in patients with Crohn’s diseaseECCO '18 Vienna
Year: 2018
Authors:

L.A. Johnson1, J.R. Dillman2, J. Hamilton1, J.M. Rubin2, P.D. Higgins3*

1University of Michigan, Internal Medicine - Gastroenterology, Ann Arbor, Michigan, USA, 2University of Michigan, Radiology, Ann Arbor, USA, 3University of Michigan, Internal Medicine - Gastroenterology, Ann Arbor, MI, USA

P290: Determination of small-bowel patency in Crohn’s disease - a prospective studyECCO '18 Vienna
Year: 2018
Authors:

A. Santos1*, M. Silva1, H. Cardoso1, R. Cunha2, A. Peixoto1, R. Gaspar1, S. Lopes1, G. Macedo1

1Centro Hospitalar de São João, Gastroenterology, Porto, Portugal, 2Centro Hospitalar de São João, Imagiology, Porto, Portugal

P291: Can the prognostic index be a predicting factor for mortality and morbidity in intestinal resection of patients with ulcerative colitis?ECCO '18 Vienna
Year: 2018
Authors:

T. Chohno*, M. Uchino, T. Minagawa, R. Kuwahara, Y. Horio, H. Sasaki, T. Bando, Y. Takesue, H. Ikeuchi

Hyogo College of Medicine, Department of Inflammatory Bowel Disease, Nishinomiya, Hyogo, Japan

P292: Faecal calprotecin may be a good predictor of histologic remission in ulcerative colitisECCO '18 Vienna
Year: 2018
Authors:

T. Knezevic Ivanovski1*, S. Knezevic Usaj2, P. Svorcan1, M. Nedeljkovic Protic1

1University Hospital Zvezdara, Gastroenterology and hepatology, Belgrade, Serbia, 2Faculty of medicine University of Novi Sad, Department of Pathology and laboratory diagnostics, Novi Sad, Serbia

P293: Influence of initial albumin levels on infliximab and adalimumab trough levels in inflammatory bowel disease patientsECCO '18 Vienna
Year: 2018
Authors:

J. Gonzalez-Lopez1, C. Llamas2, J.M. Giráldez-Montero1, R. Ferreiro3, I. Baston3, M.J. Lamas1, J.E. Dominguez-Munoz3, M. Barreiro-de Acosta3*

1University Hospital Santiago, Department of Pharmacy, Santiago, Spain, 2USC Student, Santiago, Spain, 3University Hospital Santiago de Compostela, Gastroenterology, Santiago, Spain